Loading clinical trials...
Loading clinical trials...
Phase II Study Of Gemcitabine And Docetaxel In Patients With Inoperable Stage IIIB Or IIIB or IV Non-Small Cell Lung Cancer
Conditions
Interventions
docetaxel
gemcitabine hydrochloride
Locations
12
France
Hopital Avicenne
Bobigny, France
Centre Jean Bernard
Le Mans, France
Hopital Perpetuel Secours
Levallois-Perret, France
Centre de Radiotherapie et Oncologie Saint-Faron
Mareuil-lès-Meaux, France
Clinique de Docteur Terrioux
Meaux, France
American Hospital of Paris
Neuilly-sur-Seine, France
Start Date
September 1, 2003
Last Updated
July 24, 2008
NCT07190248
NCT05198830
NCT07336732
NCT07486219
NCT06498635
NCT05692635
Lead Sponsor
GERCOR - Multidisciplinary Oncology Cooperative Group
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions